Safety
Showing 26 - 50 of 151
Tumor Infiltrating Lymphocytes, Safety, Advanced Solid Tumor Trial in Beijing (TIL therapy)
Recruiting
- Tumor Infiltrating Lymphocytes
- +5 more
- TIL therapy
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Dec 19, 2022
Helicobacter Pylori, Safety, Efficacy Trial (PyloPlus Urea Breath Test System, Stool Antigen Test)
Recruiting
- Helicobacter Pylori
- +2 more
- PyloPlus Urea Breath Test System
- Stool Antigen Test
-
Orlando, FloridaOrlando Health, Inc.
Dec 13, 2022
Locally Advanced NSCLC, Chemoradiotherapy, Cavitation Lung Trial (Upfront resection)
Not yet recruiting
- Locally Advanced Non-Small Cell Lung Cancer
- +5 more
- Upfront resection
- (no location specified)
Nov 9, 2022
Safety, Tolerance Trial in Memphis (Crystal Light (once serving), Liquid IV with amino acids (one serving), Liquid IV with amino
Recruiting
- Safety
- Tolerance
- Crystal Light (once serving)
- +3 more
-
Memphis, TennesseeCenter for Nutraceutical and Dietary Supplement Research
Oct 21, 2022
Immunogenicity, Efficacy, Safety Trial in Savannakhét (SW-BIC-213, SARS-Cov-2 Vaccina(Vero Cell ) Inactivated)
Recruiting
- Immunogenicity
- +2 more
- SW-BIC-213
- SARS-Cov-2 Vaccina(Vero Cell ) Inactivated
-
Savannakhét, Sava, Lao People's Democratic RepublicSavannakhét Provincial hospital
Oct 11, 2022
Combination of Ertugliflozin And Sitagliptin Efficacy, Safety &
Not yet recruiting
- Efficacy
- +2 more
- Combinations of Oral Blood Glucose Lowering Drugs
- (no location specified)
Oct 3, 2022
Safety Trial in Uppsala (GP0045, Restylane Lyft Lidocaine)
Completed
- Safety
- GP0045
- Restylane Lyft Lidocaine
-
Uppsala, SwedenCTC
Aug 24, 2022
Pharmacokinetics, Safety, Food-drug Interaction Trial in Miami (200 mg resveratrol as JOTROL, 500 mg resveratrol as JOTROL, 700
Completed
- Pharmacokinetics
- +2 more
- 200 mg resveratrol as JOTROL
- +3 more
-
Miami, FloridainVentiv Health Clinical Research Services LLC, a Syneos Health
Jul 13, 2022
SARS-CoV-2, Safety, Immunotoxicity Trial in Wuhan (one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006), Cellular Immunity,
Not yet recruiting
- SARS-CoV-2
- +2 more
- one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006)
- +3 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Aug 9, 2022
Safety Trial in Baton Rouge (Celastrol)
Recruiting
- Safety
- Celastrol
-
Baton Rouge, LouisianaPatient Plus Urgent Care
Aug 8, 2022
Safety Trial in Tempe (SBT115301, Placebo)
Recruiting
- Safety
- SBT115301
- Placebo
-
Tempe, ArizonaCelerion
Aug 2, 2022
Pharmacokinetics, Safety Trial in Qingdao (Reference preparation-Reference preparation-Test Preparation, Reference
Enrolling by invitation
- Pharmacokinetics
- Safety
- Reference preparation-Reference preparation-Test Preparation
- +2 more
-
Qingdao, Shandong, ChinaPhase I clinical research center
Jul 28, 2022
Pharmacokinetics, Tolerability, Safety Trial in Warngau (AP707)
Completed
- Pharmacokinetics
- +2 more
-
Warngau, Bavaria, GermanyPhase I Unit of CannaXan GmbH
Jul 25, 2022
Safety, Pharmacokinetics Trial in Sofia (single E4 30 mg, single E4 100 mg, multiple E4 100 mg)
Recruiting
- Safety
- Pharmacokinetics
- single E4 30 mg
- +3 more
-
Sofia, BulgariaMC Comac Medical Ltd
Jul 12, 2022
Safety Trial in Seattle (Family Safety Check-In, AAP Firearm Storage Web Page)
Recruiting
- Safety
- Family Safety Check-In
- AAP Firearm Storage Web Page
-
Seattle, WashingtonSeattle Children's Research Institute
Jul 5, 2022
Treatment, Efficacy, Safety Trial (Memantine Oral Tablet, GV-971 capsule)
Not yet recruiting
- Treatment
- +3 more
- Memantine Oral Tablet
- GV-971 capsule
- (no location specified)
Jul 3, 2022
Pharmacokinetics, Safety, Efficacy Trial in Dhaka (Advixa (Adalimumab))
Recruiting
- Pharmacokinetics
- +3 more
- Advixa (Adalimumab)
-
Dhaka, BangladeshideSHi
Jul 6, 2022
Anesthetics, Recovery, Drug Effect Trial in China (Remimazolam, Propofol group)
Not yet recruiting
- Anesthetics
- +5 more
- Remimazolam
- Propofol group
-
Lanzhou, Gansu, China
- +8 more
Jun 28, 2022
Prostate Cancer, Stereotactic Body Radiotherapy, High-risk Trial in Chengdu (stereotactic body radiotherapy)
Recruiting
- Prostate Cancer
- +4 more
- stereotactic body radiotherapy
-
Chengdu, Sichuan, ChinaChina, SiChuan
Jun 18, 2022
Safety Trial in Worldwide (E4/DRSP 15/3 mg combined tablet)
Recruiting
- Safety
- E4/DRSP 15/3 mg combined tablet
-
Parnu, Estonia
- +11 more
Jun 7, 2022
Caregivers, Decision Making, Alzheimer Trial in Aurora (Safety in Dementia)
Not yet recruiting
- Caregivers
- +5 more
- Safety in Dementia
- (no location specified)
May 19, 2022
Pharmacokinetics, Safety Trial (Test Preparation-Reference preparation, Reference preparation-Test Preparation)
Not yet recruiting
- Pharmacokinetics
- Safety
- Test Preparation-Reference preparation
- Reference preparation-Test Preparation
- (no location specified)
May 16, 2022